spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.

Industry Advisers

Set up in December 2009, EPC’s board of Industry Advisers help develop the content of the magazine, using first-hand experience to keep the magazine focused on the latest developments in the industry.

Anne Maria Ylisaari
Senior Manager, Global Clinical Alliances & Sourcing
Orion Pharma Development

Beatrijs Van Liedekerke
Director, Advisory Services
PricewaterhouseCoopers

Henrietta Ukwu
Senior Vice President, Global Regulatory Affairs
PPD, Inc

Jane Clarke
Director, eTMF Document Solutions and System Development
Phlexglobal 

For further information please contact:

Advertising
Jonathan Smith

Editorial
Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

View the digital version of EPC

epc
 
 
Featured in this issue
Interview
Industry Interview

Better, Faster, Stronger


Helping customers accelerate research progress is the most rewarding part of Jim Carroll’s role at iCTRS. Here, he tells EPC how to get ahead when reducing patient enrolment timelines.
DATA MANAGEMENT
Serialisation Programs

Bigger Data


Ramesh J Chougule of Infosys explains how implementing a new serialisation program – and moving away from traditional data tracking methods – can translate into improved efficiency, precision and cost-saving.
  Marketplace & Business
CRO Marketplace

Value Added

Adam M Dion
at GlobalData suggests that accomodating a diverse range of clients is the best solution to challenges facing contract research organisations - companies are now offering new services to increase revenue and appeal to firms which are set to lead future innovation.

spacer
Edited by
Dr Graham Hughes,
Consultant in
Pharmaceutical
Development
Published quarterly in
March, June,
September and December
Banner of PCI.EPC on Samedan
Banner of Samedan app.EPC on Samedan
Banner of Woodley.EPC on Samedan
 
Industry Events

Cancer Vaccines

15-16 September 2014, Holiday Inn Regents Park, London UK

The global therapeutic cancer vaccines market is expected to grow to a value of $7.8 billion by 2019. As companies look to develop new drugs to enter this rapidly growing industry, Cancer Vaccines 2014 will mark the path forward in terms of cancer vaccine research, clinical development and regulation.
More info >>

 
News and Press Releases

Towards Resolutely Smart and Multi-Functional Packaging

Some 6 months before the packaging and intralogistics “Capital Place” opens, the PACK EXPERTS Committee of the international packaging exhibition EMBALLAGE 2014 continues to reflect on the packaging of tomorrow and its added value.
More info >>

air transport logo

 

White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement